You're contacting media contact of this press release

Title: CoreAge Rx Adds Spot On to Skincare Line to Address Hyperpigmentation and Uneven Skin Tone

Wichita Falls, TX, United States, 13th Jul 2026 - CoreAge Rx, a provider of accessible health and wellness solutions, today announced the addition of Spot On to its growing line of prescription-strength skincare treatments. Developed to target visible discoloration, Spot On is a brightening topical formulated to assist patients dealing with stubborn dark spots, sun spots, post-acne marks, and overall uneven skin tone.The treatment utilizes a targeted combination of active ingredients designed to support a brighter and more balanced complexion. At the core of the formula is Hydroquinone, a prescription-strength brightening agent that focuses on reducing the appearance of excess pigmentation. To complement this action, the formula includes Kojic Acid, which provides tone-evening support to visibly reduce discoloration. Furthermore, Spot On incorporates Niacinamide to help calm the appearance of redness, support the skin's natural barrier, and improve overall clarity.Spot On is intended for focused application rather than full-face use. Patients are instructed to apply a thin layer exclusively to affected areas on clean, dry skin, strictly following the directions provided by their prescribing provider. Because the formula contains potent brightening actives, providers may recommend utilizing the treatment for a specific, predetermined window of time. Patients are also advised to avoid excess sun exposure and to maintain daily sunscreen use while utilizing the product.Access to the Spot On treatment is coordinated entirely through the CoreAge Rx digital platform. Individuals complete a confidential, 100% online health intake questionnaire, which is subsequently evaluated by a US board-certified physician. If the physician determines the treatment is medically appropriate,...

This press release is issued by King Newswire